EVMN · Evommune, Inc.
$11.06
-0.20 (-1.73%)
At close · Jul 29
Market Cap
$405.21M
Shares
36.02M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-06-02 | 2026 Annual Meeting of Stockholders | Shareholder meeting |
| 2026-04-13 | KOL Webinar Highlighting Role of MRGPRX2 in Migraine | Event |
| 2026-02-10 | Evommune EVO301 Top-Line Results from Phase 2a Trial in Moderate-to-Severe Atopic Dermatitis | Event |
Source: https://ir.evommune.com/